Training Programme in Translational Medicine and Therapeutics at the University of Cambridge: 'Novel therapeutics in multiple sclerosis and regulation of the immune system'. (360G-Wellcome-100535_Z_12_Z)

£247,313

This project has two key goals: to investigate the role of IL7 and IL7R in the pathogenesis of multiple sclerosis and, in so doing, to educate a young physician about translational medicine. It is built upon the observations that IL7R is genetically associated with multiple sclerosis and that an antibody which antagonises IL7R ameliorated the animal model of multiple sclerosis by downregulating TH17 cells. The research question is: does antagonism of the IL7/IL7receptor pathway reduce disease activity in multiple sclerosis?The applicant will first investigate the in vitro consequences to lymphocyte biology of IL7R genotype; then explore the effect of this genotype on reconstitution of the lymphocyte repertoire therapeutic depletion. Then he will take part in a first-in-human anti-IL7R antibody trial in healthy individuals and people with multiple sclerosis. He will be involved in the design and execution of the clinical trial and the parallel laboratory studies.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Region East of England
Award Date 2011-10-17T00:00:00+00:00
Sponsor(s) Prof Edward Bullmore, Prof Morris Brown
Internal ID 100535/Z/12/Z
Planned Dates: End Date 2016-01-31T00:00:00+00:00
Planned Dates: Start Date 2012-08-01T00:00:00+00:00
Amount Awarded 247313
Financial Year 2011/12
Lead Applicant Dr Onajite Kousin-Ezewu
Grant Programme: Title Translational Medicine & Therapeutics Programme Clinical PhD Fellow
Applicant Surname Kousin-Ezewu
Approval Committee PhD Studentships in Translational Medicine and Therapeutics
Recipient Org: Country United Kingdom
Recipient Org: City Cambridge
Has the grant transferred? No
Research conducted at multiple locations? No
Total amount including partnership funding 247313